Protagonist Therapeutics, Inc Shares Outstanding (Cover Page)
Protagonist Therapeutics, Inc (PTGX) had Shares Outstanding (Cover Page) of 64.71 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 64.71M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 64.31M shares.
- 2026-02-18: Entity Common Stock, Shares Outstanding 63.81M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 62.52M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 64.71M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 64.31M shares 10-Q · filed 2026-05-05 |
| 2026-02-18 | 63.81M shares 10-K · filed 2026-02-25 |
| 2025-10-29 | 62.52M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 62.21M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 61.98M shares 10-Q · filed 2025-05-06 |
| 2025-02-19 | 61.38M shares 10-K · filed 2025-02-21 |
| 2024-10-31 | 59.60M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 58.90M shares 10-Q · filed 2024-08-06 |
| 2024-04-30 | 58.65M shares 10-Q · filed 2024-05-07 |
| 2024-02-22 | 58.27M shares 10-K · filed 2024-02-27 |
| 2023-10-27 | 57.68M shares 10-Q · filed 2023-11-02 |
| 2023-07-31 | 57.53M shares 10-Q · filed 2023-08-03 |
| 2023-04-28 | 57.25M shares 10-Q · filed 2023-05-04 |
| 2023-03-02 | 51.28M shares 10-K · filed 2023-03-15 |
| 2022-10-31 | 49.20M shares 10-Q · filed 2022-11-08 |
| 2022-07-28 | 49.08M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 48.66M shares 10-Q · filed 2022-05-05 |
| 2022-02-15 | 48.41M shares 10-K · filed 2022-02-28 |
| 2021-10-29 | 47.73M shares 10-Q · filed 2021-11-03 |
| 2021-07-30 | 47.55M shares 10-Q · filed 2021-08-04 |
| 2021-04-30 | 43.95M shares 10-Q · filed 2021-05-04 |
| 2021-02-26 | 43.81M shares 10-K · filed 2021-03-10 |
| 2020-10-30 | 38.26M shares 10-Q · filed 2020-11-04 |
| 2020-07-31 | 36.81M shares 10-Q · filed 2020-08-06 |
| 2020-04-30 | 27.43M shares 10-Q · filed 2020-05-07 |
| 2020-02-28 | 27.29M shares 10-K · filed 2020-03-10 |
| 2019-10-31 | 27.21M shares 10-Q · filed 2019-11-06 |
| 2019-07-31 | 26.28M shares 10-Q · filed 2019-08-07 |
| 2019-04-30 | 23.40M shares 10-Q · filed 2019-05-08 |
| 2019-02-28 | 23.35M shares 10-K · filed 2019-03-12 |
| 2018-10-31 | 24.19M shares 10-Q · filed 2018-11-06 |
| 2018-07-31 | 21.22M shares 10-Q · filed 2018-08-07 |
| 2018-04-30 | 21.20M shares 10-Q · filed 2018-05-09 |
| 2018-02-28 | 21.10M shares 10-K · filed 2018-03-07 |
| 2017-10-31 | 20.48M shares 10-Q · filed 2017-11-07 |
| 2017-07-31 | 16.90M shares 10-Q · filed 2017-08-08 |
| 2017-04-28 | 16.86M shares 10-Q · filed 2017-05-10 |
| 2017-02-28 | 16.79M shares 10-K · filed 2017-03-07 |
| 2016-10-31 | 16.71M shares 10-Q · filed 2016-11-14 |
| 2016-08-31 | 16.46M shares 10-Q · filed 2016-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |